[1] 王贝贝,林毅,张秋业,等.复发性横纹肌溶解症1例及基因分析[J].中华实用儿科临床杂志,2019,34(5):383-385.
[2] CHAVEZ L O, LEON M, EINAV S, et al.Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice[J]. Crit Care, 2016, 20(1): 135.
[3] ZUTT R, VAN DER KOOI A J, LINTHORST G E, et al. Rhabdomyolysis: review of the literature[J]. Neuromuscul Disord, 2014, 24(8): 651-659.
[4] HERRÁEZ GARCÍA J, TORRACCHI CARRASCO A M, ANTOLÍ-ROYO A C, et al. Rhabdomyolysis. A descriptive study of 449 patients[J]. Med Clin (Barc), 2012, 139(6): 238-242.
[5] RODRÍGUEZ E, SOLER M J, RAP O, et al. Risk factors for acute kidney injury in severe rhabdomyolysis[J]. PLoS One, 2013, 8(12): e8299212.
[6] MCMAHON G M, ZENG X, Waikar S S.A risk prediction score for kidney failure or mortality in rhabdomyolysis[J]. JAMA Intern Med, 2013, 173(19):1821-1828.
[7] RAWSON E S, CLARKSON P M, TARNOPOLSKY M A. Perspectives on exertional rhabdomyolysis[J]. Sports Med, 2017, 47(Suppl 1): 33-49.
[8] 卿胜强,张静波.横纹肌溶解致急性肾损伤1例并文献复习[J].重庆医学,2018,47(6):863-864.
[9] ZUTT R, VAN DER KOOI A J, LINTHORST G E, et al. Recurrent rhabdomyolysis: screening for underlying disease[J]. Ned Tijdschr Geneeskd, 2010, 154: A2290.
[10] SCALCO R S, GARDINER A R, PITCEATHLY R D, et al.Rhabdomyolysis: a genetic perspective[J]. Orphanet J Rare Dis, 2015, 10:51.
[11] TORRES P A, HELMSTETTER J A, KAYE A M, et al.Rhabdomyolysis: pathogenesis, diagnosis, and treatment[J]. Ochsner J, 2015, 15(1): 58-69.
[12] ZIMMERMAN J L, SHEN M C.Rhabdomyolysis[J]. Chest, 2013, 144(3): 1058-1065.
[13] 赫广玉,王桂侠.糖尿病急性并发症与横纹肌溶解综合征[J].中国糖尿病杂志,2018,26(3):261-264.
[14] BOSCH X, POCH E, GRAU J M.Rhabdomyolysis and acute kidney injury[J]. N Engl J Med, 2009, 361(1): 62-72.
[15] STAHL K, RASTELLI E, SCHOSER B.A systematic review on the definition of rhabdomyolysis[J]. J Neurol, 2019,doi:10.1007/s00415-019-09185-4.
[16] PETEJOVA N, MARTINEK A.Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review[J]. Crit Care, 2014, 18(3): 224.
[17] VERRENGIA E P.Rhabdomyolysis. Emergencies in neuromuscular disease[M]. Berlin:Springer Cham,2017:99-109.
[18] BAGLEY W H, YANG H, SHAH K H.Rhabdomyolysis[J]. Intern Emerg Med, 2007, 2(3):210-218.
[19] 刘艳,应俊,吴红华,等.横纹肌溶解症62例诊治分析[J].浙江医学,2019, 41(15):1641-1644.
[20] AL MANASRA A R A, SHATTARAH O K. Massive rhabdomyolysis; a rare cause of hepatocellular dysfunction[J]. Am J Case Rep, 2018, 19:105-108.
[21] ZENG X,ZHANG L,WU T,et al.Continuous renal replacement therapy (CRRT) for rhabdomyolysis[J]. Cochrane Database Sys Rev, 2014, (6):CD008566.
[22] 何建三,王锦权,陶晓根,等.横纹肌溶解综合征患者预后影响因素分析[J].中国急救医学,2019,39(1):43-47. |
